Literature DB >> 18723001

Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice.

Rei Naitoh1, Kazumasa Miyawaki, Norio Harada, Wataru Mizunoya, Kentaro Toyoda, Tohru Fushiki, Yuichiro Yamada, Yutaka Seino, Nobuya Inagaki.   

Abstract

Gastric inhibitory polypeptide (GIP) is an incretin and directly promotes fat accumulation in adipocytes. Inhibition of GIP signaling prevents onset of obesity and increases fat oxidation in peripheral tissues under high-fat diet (HFD), but the mechanism is unknown. In the present study, we investigated the effects of inhibition of GIP signaling on adiponectin levels after 3 weeks of HFD by comparing wild-type (WT) mice and GIP receptor-deficient (Gipr(-/-)) mice. In HFD-fed Gipr(-/-) mice, fat oxidation was significantly increased and adiponectin mRNA levels in white adipose tissue and plasma adiponectin levels were significantly increased compared to those in HFD-fed WT mice. In addition, the PPARalpha mRNA level was increased and the ACC mRNA level was decreased in skeletal muscle of HFD-fed Gipr(-/-) mice compared with those in HFD-fed WT mice. These results indicate that inhibition of GIP signaling increases adiponectin levels, resulting in increased fat oxidation in peripheral tissues under HFD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723001     DOI: 10.1016/j.bbrc.2008.08.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice.

Authors:  Farnaz Keyhani-Nejad; Martin Irmler; Frank Isken; Eva K Wirth; Johannes Beckers; Andreas L Birkenfeld; Andreas F H Pfeiffer
Journal:  Diabetologia       Date:  2014-10-28       Impact factor: 10.122

2.  Effects of sleeve gastrectomy on lipid metabolism in an obese diabetic rat model.

Authors:  Yuichiro Kawano; Masayuki Ohta; Teijiro Hirashita; Takashi Masuda; Masafumi Inomata; Seigo Kitano
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

3.  Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.

Authors:  Randi Ugleholdt; Jens Pedersen; Maria Rosaria Bassi; Ernst-Martin Füchtbauer; Signe Marie Jørgensen; Hanne-Louise Kissow; Nikolaj Nytofte; Steen Seier Poulsen; Mette Marie Rosenkilde; Yutaka Seino; Peter Thams; Peter Johannes Holst; Jens Juul Holst
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

4.  Intestinal FFA3 mediates obesogenic effects in mice on a Western diet.

Authors:  Kristen R Lednovich; Chioma Nnyamah; Sophie Gough; Medha Priyadarshini; Kai Xu; Barton Wicksteed; Sidharth Mishra; Shalini Jain; Joseph L Zapater; Hariom Yadav; Brian T Layden
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-20       Impact factor: 5.900

Review 5.  Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.

Authors:  N Irwin; P R Flatt
Journal:  Diabetologia       Date:  2009-06-17       Impact factor: 10.122

Review 6.  The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?

Authors:  Ricardo Godinho; Cristina Mega; Edite Teixeira-de-Lemos; Eugénia Carvalho; Frederico Teixeira; Rosa Fernandes; Flávio Reis
Journal:  J Diabetes Res       Date:  2015-05-17       Impact factor: 4.011

Review 7.  GIP and GLP-1, the two incretin hormones: Similarities and differences.

Authors:  Yutaka Seino; Mitsuo Fukushima; Daisuke Yabe
Journal:  J Diabetes Investig       Date:  2010-04-22       Impact factor: 4.232

Review 8.  Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.

Authors:  Yutaka Seino; Daisuke Yabe
Journal:  J Diabetes Investig       Date:  2013-03-18       Impact factor: 4.232

9.  GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.

Authors:  Shu-Chen Lu; Michelle Chen; Larissa Atangan; Elizabeth A Killion; Renee Komorowski; Yuan Cheng; Chawita Netirojjanakul; James R Falsey; Marina Stolina; Denise Dwyer; Clarence Hale; Shanaka Stanislaus; Todd Hager; Veena A Thomas; John M Harrold; David J Lloyd; Murielle M Véniant
Journal:  Cell Rep Med       Date:  2021-04-30

Review 10.  A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Authors:  Ryan P Ceddia; Sheila Collins
Journal:  Clin Sci (Lond)       Date:  2020-03-13       Impact factor: 6.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.